Suraksha Diagnostic Limited (NSE:SURAKSHA)

India · Delayed Price · Currency is INR

268.25

+0.20 (0.07%)

Jun 15, 2026, 3:30 PM IST

-18.10% (1Y)

Market Cap	13.96B -18.2%
Revenue (ttm)	3.10B +23.1%
Net Income	321.87M +1.1%
EPS	6.18 +3.5%
Shares Out	52.08M
PE Ratio	43.37
Forward PE	34.81
Dividend	0.50 (0.19%)
Ex-Dividend Date	n/a

Volume	23,714
Open	269.40
Previous Close	268.05
Day's Range	265.20 - 274.20
52-Week Range	224.10 - 352.50
Beta	n/a
Analysts	Hold
Price Target	285.00 (+6.24%)
Earnings Date	May 21, 2026

About Suraksha Diagnostic

Suraksha Diagnostic Limited operates a chain of diagnostic centers in India. It offers pathology testing services, such as microbiology, serology, molecular biology, histopathology, cytopathology, clinical pathology, and haematology; genomics testing, including microarray, noninvasive prenatal, quantitative fluorescent polymerase chain reaction, fluorescence in situ hybridization, and karyotyping; and radiology testing that includes X ray, magnetic resonance imaging, computed tomography scan, USG, DEXA scan, OPG, and mammography. The company al... [Read more]

Industry Diagnostics & Research

Sector Healthcare

Founded 1992

Employees 1,300

Stock Exchange National Stock Exchange of India

Ticker Symbol SURAKSHA

Full Company Profile

Financial Performance

In fiscal year 2026, Suraksha Diagnostic's revenue was 3.10 billion, an increase of 23.13% compared to the previous year's 2.52 billion. Earnings were 321.87 million, an increase of 1.14%.

Financial Statements